more information

Category:

Biologically Active Peptides

reference

1. T. Kita, C.E. Smith, K.F. Fok, K.L. Duffin, W.M. Moore, P.J. Karabatsos, J.F. Kachur, F.K. Hamra, N.V. Pidhorodeckyj, L.R. Forte, and M.G. Currie, Am. J. Physiol., 266, F342 (1994). (Original)
2. M. Nakazato, H. Yamaguchi, H. Kinoshita, K. Kangawa, H. Matsuo, N. Chino, and S. Matsukura, Biochem. Biophys. Res. Commun., 220, 586 (1996). (Biologically Active / Inactive isomer)
3. H. Kinoshita, S. Fujimoto, M. Nakazato, N. Yokota, Y. Date, H. Yamaguchi, S. Hisanaga, and T. Eto, Kidney Int., 52, 1028 (1997). (Urine/Plasma Level; Renal Disease)
4. N. Chino, S. Kubo, T. Kitani, T. Yoshida, R. Tanabe, Y. Kobayashi, M. Nakazato, K. Kangawa, and T. Kimura, FEBS Lett., 421, 27 (1998). (Biochem.; Topological Isomers)
5. N.G. Moss, D.A. Riguera, R.M. Solinga,M.M. Kessler, D.P. Zimmer,W.J. Arendshorst, M.G. Currie, and M.F. Goy, Hypertension, 53, 867 (2009). (Natriuretic Activity of Topological Isomers)
6. L.R. Forte and M.G. Currie, FASEB J., 9, 643 (1995). (Review)
7. L.R. Forte, X.H. Fan, and F.K. Hamra, Am. J. Kidney Dis., 28, 296 (1996). (Review)
8. L.R. Forte, Pharmacol. Ther., 104, 137 (2004). (Review)